Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Oryzon Genomics S.A.

ORYZFPNK
Healthcare
Biotechnology
$3.60
$0.00(0.00%)
U.S. Market opens in 8h 16m

ORYZF News Today: Stay Updated with the Latest Oryzon Genomics S.A. News in Real Time

Find ORYZF news now at Meyka AI. Stay informed with the latest Oryzon Genomics S.A. stocks updates, including price news, market analysis, and expert insights.

ARKK ETF Down Over 50% as Nasdaq 100 Gains 80%
📅 8 days ago

ARKK ETF Down Over 50% as Nasdaq 100 Gains 80%

The ARKK ETF, led by Cathie Wood, has hit a painful milestone. Five years after the pandemic market crash, ARKK is down more than 50 percent from its peak, while the Nasdaq 100 has gained nearly 80 percent in the same period. This sharp gap has raised one big question among investors: Has the high-growth…

Read more
ALINT.PA IntegraGen EURONEXT +12.12% pre-market 22 Jan 2026: volume spike watch
📅 1 month ago

ALINT.PA IntegraGen EURONEXT +12.12% pre-market 22 Jan 2026: volume spike watch

ALINT.PA stock jumps pre-market 12.12% on EUR volume surge; quick analysis, Meyka AI forecast and trade levels for IntegraGen SA

Read more
December 31: WHO Genomics Equity Gaps Put Trial Funding at Risk
📅 2 months ago

December 31: WHO Genomics Equity Gaps Put Trial Funding at Risk

WHO report finds major equity gaps in genomics research. For US investors, health equity will shape trial funding, compliance, and procurement. See key risks and actions.

Read more
Why Cathie Wood Trimmed $40 Million of Megacap Tech Holdings in December 2025
📅 2 months ago

Why Cathie Wood Trimmed $40 Million of Megacap Tech Holdings in December 2025

In December 2025, Cathie Wood surprised many investors after trimming nearly $40 million worth of megacap technology holdings across her flagship innovation focused funds. The move came during a period when large technology stocks were still dominating the stock market, driven by strong earnings, AI optimism, and resilient investor demand. This decision has raised important…

Read more
Bankruptcy Court Clears Sale of 23andMe to Co-founder’s Nonprofit
📅 8 months ago

Bankruptcy Court Clears Sale of 23andMe to Co-founder’s Nonprofit

23andMe, a former giant in home DNA testing, now has a fresh start. After going bankrupt earlier this year, a U.S. court has now approved its sale, but not to a tech giant or drug company. Instead, the company is being bought by a nonprofit led by its co-founder, Anne Wojcicki. This move is big….

Read more
Reasons why NVDA stocks rising for consecutive 3 days
📅 1 year ago

Reasons why NVDA stocks rising for consecutive 3 days

Nvidia’s stock has been on fire, climbing for three straight days and grabbing Wall Street’s attention. Investors are watching closely as the tech giant continues to dominate the AI chip market. The latest surge comes after big announcements from major players like Google and OpenAI. It pushes demand for Nvidia’s cutting-edge technology even higher. Nvidia’s…

Read more

ORYZF News FAQ